Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Some people experienced hair loss after COVID-19 vaccination, but it's very rare and vaccines' benefits are greater than this risk.

The new SFS Scale predicts hair transplant difficulty using hair and skin types, with thick skin and coily hair being hardest to work with.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

The Hairless gene is crucial for healthy skin and hair growth.

PUVA treatment led to significant hair regrowth in over half of the patients with alopecia areata totalis and universalis.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

A woman with Kallman's syndrome also developed alopecia universalis, a condition not previously linked to Kallman's.

A specific gene mutation causes congenital hair loss.

Adalimumab may cause severe hair loss in some patients.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Alopecia universalis can be an early sign of HIV.

Serum from alopecia patients does not stop hair growth in grafted skin on mice.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

HLA-DRB5 and other genes may be linked to alopecia universalis.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

A dog with complete hair loss regrew most hair after treatment, with no relapse after stopping treatment.

Baricitinib successfully treated severe hair loss.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

A man had an unusual type of hair loss that didn't match known patterns and didn't improve with treatment.

Hispanic/Latinx patients with alopecia areata often have it before age 40, with females and certain health conditions like rheumatoid arthritis more commonly affected.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Alopecia areata is a hair loss condition that often starts before age 30 and can affect various body parts, with unpredictable hair regrowth chances.